PulseAugur
EN
LIVE 02:25:48

Radiogenomic models predict glioblastoma immune signatures

By PulseAugur Editorial · [1 sources] ·

Researchers have developed radiogenomic models capable of non-invasively predicting a specific immune cell signature in glioblastoma. These models utilize radiomic features extracted from MRI scans and transcriptomic data to identify macrophage subtype M0 immune signatures. The study, involving 176 patients across multiple datasets, demonstrated stable performance and potential for stratifying patients for immunotherapy in future clinical trials. AI

IMPACT This research offers a non-invasive method to predict patient immune signatures, potentially improving immunotherapy stratification for glioblastoma.

RANK_REASON The cluster contains an academic paper detailing a new research methodology and findings. [lever_c_demoted from research: ic=1 ai=1.0]

Read on arXiv cs.LG →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Radiogenomic models predict glioblastoma immune signatures

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Tool
The cluster contains an academic paper detailing a new research methodology and findings. [lever_c_demoted from research: ic=1 ai=1.0]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
paper, safety
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
High
Clearly on-topic for AI-industry coverage.
Story freshness
148 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. arXiv cs.LG TIER_1 English(EN) · Thomas Booth ·

    Predictive Radiomics for Evaluation of Cancer Immune SignaturE in Glioblastoma: the PRECISE-GBM study

    Background: Radiogenomics allows identification of radiological biomarkers for genomic phenotypes. In glioblastoma, these biomarkers could potentially complement patient stratification strategies. We aim to develop and analytically validate radiological biomarkers that capture im…

RELATED ENTITIES

RELATED TOPICS